Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodi... by Zhiliang Guo, Rula Sa, Daqiang Zhao, Songxia Li, Hui Guo, Lan Zhu, Gang Chen

Get full text

Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better by Lan Zhu, Lei Zhang, Wenjun Shang, Wenhua Liu, Rula Sa, Zhiliang Guo, Longshan Liu, Jinghong Tan, Hengxi Zhang, Yonghua Feng, Wenyu Zhao, Wenqi Cong, Jianyong Wu, Changxi Wang, Gang Chen, Sihan Zhou

Get full text